Pharmaceutical Bio Association Extends Chairman Won Hee-mok's Term Until February 2023
Won Hee-mok, President of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association
View original image[Asia Economy Reporter Seo So-jeong] The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on the 19th that Chairman Won Hee-mok's term has been extended until February 2023.
The association's board of directors held the first meeting of 2021 in the afternoon and unanimously approved the extension of Chairman Won's term.
According to the articles of association, the chairman's term is two years, with one possible reappointment, and only reappointed chairmen can have their term extended once more by a special resolution of the board.
Chairman Won assumed office as the 21st chairman in February 2017 and was reappointed for another two-year term in February 2019.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The board stated, "Considering the public's expectations for the pharmaceutical and bio-pharma industry amid COVID-19, we judged that Chairman Won, who has led the association so far, is the right person to achieve global success for our industry."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
